On January 11, 2023, the Department of Health and Human Services (HHS) Secretary Xavier Becerra extended the COVID-19 Public Health Emergency (PHE) declaration. The PHE is now set to expire on April 11, 2023.
During the PHE the Centers for Medicare & Medicaid Services (CMS) temporarily approved a number of telehealth flexibilities. With the Omnibus that passed at the end of 2022, these telehealth flexibilities were extended for two years, and are set to expire December 31, 2024.
While the Association for Clinical Oncology (the Association) has been advocating for permanent extension of telehealth flexibilities, this will allow Congress time to study how telehealth is being used, create parameters to avoid abuse, and identify a way to pay for the permanent expansion.
For more information on the flexibilities and waivers CMS put in place during the PHE, please refer to the American Society of Clinical Oncology’s COVID-19 Government, Reimbursement, and Regulatory Updates page.
Bookmark ASCO in Action for news, advocacy, and analysis on cancer policy.